Spark Investment Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
CCM
MC
OIM
ACH
AIM
RCM
Spark Investment Management's PACB Position: Q1 2018 in Review
Spark Investment Management sold out of Pacific Biosciences (PACB) in Q1 2018, closing a stake of 267,000 shares — an estimated $704K sold.
Spark Investment Management first reported a position in PACB in Q2 2013 and held it in 13 quarters. The position peaked at $2.83M in Q1 2014. 101 funds tracked by Wall St. Rank hold PACB as of Q1 2018.
- Spark Investment Management reported no remaining Pacific Biosciences position as of Q1 2018 after selling out during the quarter.
- Spark Investment Management sold 267,000 Pacific Biosciences shares in Q1 2018, an estimated $704K.
- Spark Investment Management first reported a position in Pacific Biosciences in Q2 2013 and held it in 13 quarters.
- Spark Investment Management's Pacific Biosciences position peaked at $2.83M in Q1 2014.
- 101 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2018.
Based on Spark Investment Management's 13F filing for Q1 2018, filed 10 May 2018.